No abstract available
MeSH terms
-
Carcinoma, Renal Cell / drug therapy
-
Carcinoma, Renal Cell / secondary*
-
Combined Modality Therapy
-
Humans
-
Hypothyroidism / chemically induced*
-
Interleukin-2 / adverse effects*
-
Male
-
Melanoma / drug therapy
-
Melanoma / secondary*
-
Middle Aged